Filling critical evidence generation gaps with global oncology real-world data

There is increasing demand for local data as regulatory and HTA bodies have stated a clear preference in RWE guidances. Watch Flatiron’s Blythe Adamson MD, Head of Outcomes Research & Evidence Generation, share more about how we’re filling the gap with RWD from the US, UK, Germany, and Japan.